Attenuation of TNF-driven Murine Ileitis by Intestinal Expression of the Viral Immunomodulator CrmD

Overview

Journal Mucosal Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2010 Jul 29

PMID 20664576

Citations 10

Authors

A Viejo-Borbolla

A P Martin

L R Muniz

L Shang

F Marchesi

N Thirunarayanan

N Harpaz

R A Garcia

M Apostolaki

G C Furtado

L Mayer

G Kollias

A Alcami

S A Lira

Affiliations

Soon will be listed here.

Abstract

Tumor necrosis factor α (TNFα) is a key pathogenic factor in Crohn's disease and rheumatoid arthritis. TNF(ΔARE) mice express high levels of TNFα and present Crohn's-like ileitis and arthritis. Alterations in the chemokine network could underline the TNF-driven ileitis. The aim of this study was to evaluate the role of TNF and chemokines in ileitis using ectromelia virus cytokine response modifier D (CrmD), a protein that binds TNFα and a limited number of chemokines. We generated transgenic mice expressing CrmD in intestinal epithelial cells (vCrmD mice) and crossed them with the TNF(ΔARE) mice to test whether CrmD could affect TNF-driven inflammatory processes. During homeostasis, only the number of B cells in the lamina propria was reduced by CrmD expression. Interestingly, CrmD expression in the intestine markedly attenuated the inflammatory infiltrates in the ileum of TNF(ΔARE) mice, but did not affect development of arthritis. Our results suggest that CrmD affects development of ileitis by locally affecting both TNF and chemokine function in the ileum.

Citing Articles

The TNF Mouse as a Model of Intestinal Fibrosis.

Steiner C, Koch S, Evanoff T, Welch N, Kostelecky R, Callahan R Am J Pathol. 2023; 193(8):1013-1028.

PMID: 37169343 PMC: 10433691. DOI: 10.1016/j.ajpath.2023.04.009.

The binding and specificity of chemokine binding proteins, through the lens of experiment and computation.

Stark L, Guan W, Colvin M, LiWang P Biomed J. 2021; 45(3):439-453.

PMID: 34311129 PMC: 9421921. DOI: 10.1016/j.bj.2021.07.004.

Deriving Immune Modulating Drugs from Viruses-A New Class of Biologics.

Yaron J, Zhang L, Guo Q, Burgin M, Schutz L, Awo E J Clin Med. 2020; 9(4).

PMID: 32244484 PMC: 7230489. DOI: 10.3390/jcm9040972.

Addition of a Viral Immunomodulatory Domain to Etanercept Generates a Bifunctional Chemokine and TNF Inhibitor.

Alejo A, Sanchez C, Amu S, Fallon P, Alcami A J Clin Med. 2019; 9(1).

PMID: 31877657 PMC: 7020083. DOI: 10.3390/jcm9010025.

Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation.

Alejo A, Ruiz-Arguello M, Pontejo S, Del Mar Fernandez de Marco M, Saraiva M, Hernaez B Nat Commun. 2018; 9(1):1790.

PMID: 29724993 PMC: 5934441. DOI: 10.1038/s41467-018-04098-8.

References

Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T . Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J Exp Med. 2002; 196(12):1563-74. PMC: 2196068. DOI: 10.1084/jem.20020281. View

Burns R, Rivera-Nieves J, Moskaluk C, Matsumoto S, Cominelli F, Ley K . Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology. 2001; 121(6):1428-36. DOI: 10.1053/gast.2001.29568. View

Pinto D, Robine S, Jaisser F, El Marjou F, Louvard D . Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem. 1999; 274(10):6476-82. DOI: 10.1074/jbc.274.10.6476. View

Zlotnik A, Yoshie O . Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12(2):121-7. DOI: 10.1016/s1074-7613(00)80165-x. View

Le Y, Zhou Y, Iribarren P, Wang J . Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol. 2005; 1(2):95-104. View

Gileva I, Nepomnyashchikh T, Antonets D, Lebedev L, Kochneva G, Grazhdantseva A . Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. Biochim Biophys Acta. 2006; 1764(11):1710-8. PMC: 9628946. DOI: 10.1016/j.bbapap.2006.09.006. View

Jamieson T, Cook D, Nibbs R, Rot A, Nixon C, McLean P . The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005; 6(4):403-11. DOI: 10.1038/ni1182. View

Behm B, Bickston S . Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2008; (1):CD006893. DOI: 10.1002/14651858.CD006893. View

Yadav P, Liu Z . Current strategies for the treatment of ulcerative colitis. Recent Pat Inflamm Allergy Drug Discov. 2009; 3(1):65-72. DOI: 10.2174/187221309787158407. View

10.

Shang L, Fukata M, Thirunarayanan N, Martin A, Arnaboldi P, Maussang D . Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology. 2008; 135(2):529-38. PMC: 2598776. DOI: 10.1053/j.gastro.2008.04.020. View

11.

Martin A, Canasto-Chibuque C, Shang L, Rollins B, Lira S . The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol. 2006; 177(10):7296-302. DOI: 10.4049/jimmunol.177.10.7296. View

12.

Alejo A, Ruiz-Arguello M, Ho Y, Smith V, Saraiva M, Alcami A . A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A. 2006; 103(15):5995-6000. PMC: 1458686. DOI: 10.1073/pnas.0510462103. View

13.

Papadakis K, Targan S . Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000; 51:289-98. DOI: 10.1146/annurev.med.51.1.289. View

14.

Kunkel E, Campbell D, Butcher E . Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation. 2003; 10(3-4):313-23. DOI: 10.1038/sj.mn.7800196. View

15.

Dahan S, Roth-Walter F, Arnaboldi P, Agarwal S, Mayer L . Epithelia: lymphocyte interactions in the gut. Immunol Rev. 2007; 215:243-53. PMC: 3864677. DOI: 10.1111/j.1600-065X.2006.00484.x. View

16.

Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y . Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008; 14(33):5154-61. PMC: 2744005. DOI: 10.3748/wjg.14.5154. View

17.

Brown S, Mayer L . The immune response in inflammatory bowel disease. Am J Gastroenterol. 2007; 102(9):2058-69. DOI: 10.1111/j.1572-0241.2007.01343.x. View

18.

Shang L, Thirunarayanan N, Viejo-Borbolla A, Martin A, Bogunovic M, Marchesi F . Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine. Gastroenterology. 2009; 137(3):1006-18, 1018.e1-3. PMC: 2736321. DOI: 10.1053/j.gastro.2009.05.055. View

19.

Das G, Augustine M, Das J, Bottomly K, Ray P, Ray A . An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A. 2003; 100(9):5324-9. PMC: 154344. DOI: 10.1073/pnas.0831037100. View

20.

Wright T, Pryhuber G, Chess P, Wang Z, Notter R, Gigliotti F . TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J Immunol. 2004; 172(4):2511-21. DOI: 10.4049/jimmunol.172.4.2511. View